Morbidity and mortality in paid Austrian plasma donors infected with hepatitis C at plasma donation in the 1970s.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Hepatology

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JHEP.2007.01.023PMID 17335929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C infection and alcohol use: A dangerous mix for the liver and antiviral immunity.

  2006cited by this paper
• The natural history of compensated cirrhosis due to hepatitis C virus: A 17‐year cohort study of 214 patients

  2006cited by this paper
• HCV natural history: the retrospective and prospective in perspective.

  2005cited by this paper
• Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany--a 25-year multicenter study.

  2005cited by this paper
• Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

  2004cited by this paper
• Alcohol and Hepatitis C

  2004cited by this paper
• High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C

  2003cited by this paper
• Alcohol use and hepatitis C

  2002cited by this paper
• Clinical course of hepatitis C virus during the first decade of infection: cohort study

  2002cited by this paper
• Hepatitis C virus infection.

  2001cited by this paper
• The role of liver biopsy in chronic hepatitis C

  2001cited by this paper
• Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.

  2000cited by this paper
• The natural history of hepatitis C virus infection: host, viral, and environmental factors.

  2000cited by this paper
• 45-Year Follow-up of Hepatitis C Virus Infection in Healthy Young Adults

  2000cited by this paper
• Rising Incidence of Hepatocellular Carcinoma in the United States

  1999cited by this paper
• Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.

  1999cited by this paper
• Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.

  1999cited by this paper
• Rising incidence of hepatocellular carcinoma in the United States.

  1999cited by this paper
• The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre

  1999cited by this paper
• Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

  1997cited by this paper
• Clinical outcomes after transfusion-associated hepatitis C.

  1995cited by this paper
• The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

  1992cited by this paper
• The natural history of community-acquired hepatitis C in the United States.

  1992cited by this paper
• Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group.

  1992cited by this paper
• Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis

  1992cited by this paper
• Cancer survival corrected for heterogeneity in patient withdrawal.

  1982cited by this paper
• Non A-non B-Hepatitisepidemie bei einer Plasmapheresestelle

  1979cited by this paper
• Sex differences in the survival of lung cancer patients

  1962cited by this paper
• Sex differences in the survival of lung cancer patients.

  1962cited by this paper

• Colorectal cancer screening to identify undiagnosed hepatitis C in an Austrian cohort.

  2025cites this paper
• MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective

  2021cites this paper
• Spending on Hepatitis C Antivirals in the United States and Canada, 2014 to 2018.

  2020cites this paper
• Long-Term Follow-Up of a Portuguese Single-Centre Cohort of Persons with Haemophilia and Hepatitis C Virus Infection

  2020cites this paper
• SOCS1 and pattern recognition receptors: TLR9 and RIG-I; novel haplotype associations in Egyptian fibrotic/cirrhotic patients with HCV genotype 4

  2017cites this paper
• Progression of hepatitis C in the haemophiliac population in Ireland, after 30 years of infection in the pre‐DAA treatment era

  2017cites this paper
• Hepatitis C virus infection

  2017cites this paper
• Global epidemiology and burden of HCV infection and HCV-related disease

  2017cites this paper
• CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment

  2016cites this paper
• Natural history of chronic hepatitis C

  2016cites this paper
• Alcoholic liver disease: Clinical and translational research.

  2015cites this paper
• New methods to detect liver fibrosis severity and predict clinical outcomes in chronic hepatitis C infection

  2015cites this paper
• Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage: a hospital‐based linkage study

  2015cites this paper
• Hepatitis-C-Koinfektionen

  2015cites this paper
• Successful anti‐viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C

  2015cites this paper
• Impact of IL 12 B Gene rs 3212227 Polymorphism on Fibrosis , Liver Inflammation , and Response to Treatment in Genotype 4 Egyptian Hepatitis C Patients

  2015cites this paper
• The role of stromal cells in Hepatitis C virus infection

  2015cites this paper
• IN VITRO NEUTRALIZATION OF HCV BY GOAT ANTIBODIES AGAINST PEPTIDES ENCOMPASSING REGIONS DOWNSTREAM OF HVR-1 OF E2 GLYCOPROTEIN

  2014cites this paper
• Evaluation of liver disease progression in the German hepatitis C virus (1b)‐contaminated anti‐D cohort at 35 years after infection

  2014cites this paper
• Fibrosis progression in interferon treatment-naive Chinese plasma donors with chronic hepatitis C for 20 years: a cohort study.

  2014cites this paper
• Revisiting liver disease progression in HIV/HCV‐coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3

  2014cites this paper
• Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.

  2014cites this paper
• The impact of nutritional supplementation on quality of life in patients infected with hepatitis C virus.

  2013cites this paper
• Impact of IL12B Gene rs 3212227 Polymorphism on Fibrosis, Liver Inflammation, and Response to Treatment in Genotype 4 Egyptian Hepatitis C Patients

  2013cites this paper
• Outcome of hepatitis C virus infection in Chinese paid plasma donors: A 12–19‐year cohort study

  2012cites this paper
•  Natural history of hepatitis C virus infection in a cohort of asymptomatic post-transfused subjects.

  2012cites this paper
• Gender Differences in Patient Receiving Liver Transplantation for Viral Hepatitis

  2012cites this paper
• Gender differences in patient receiving liver transplantation for viral hepatitis.

  2012cites this paper
• Magnetic resonance imaging for the assessment of liver function

  2011cites this paper
• Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2

  2011cites this paper
• [Quality of life in patients with chronic hepatitis C].

  2011cites this paper
• CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

  2010cites this paper
• Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.

  2010cites this paper
• A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus.

  2010cites this paper
• Legionella, springtime and potting soils.

  2010cites this paper
• Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection.

  2010cites this paper
• Chronic hepatitis C in Austria, 1992-2006: genotype distribution and demographic factors.

  2010cites this paper
• Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats

  2009cites this paper
• Estimating the incidence, prevalence and clinical burden of hepatitis C over time in Italy

  2009cites this paper
• The history of the “natural history” of hepatitis C (1968–2009)

  2009cites this paper
• A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland

  2009cites this paper
• Recent advances in viral hepatitis.

  2009cites this paper
• Hepatocellular carcinoma in long‐term sustained virological responders following antiviral combination therapy for chronic hepatitis C

  2008cites this paper
• A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa‐2a in hepatitis C virus genotypes 2 and 3

  2008cites this paper
• Hepatitis C vaccine: supply and demand.

  2008cites this paper
• Chronic hepatitis C: Portrait of a silent epidemic and the etiologic agent

  2008cites this paper
• Genotypische Charakterisierung von Resistenzmutationen in der Hepatitis C Virus-Quasispezies unter Therapie mit einem Hepatitis C-spezifischen Proteaseinhibitor

  2008cites this paper
• Outcome of hepatitis C infection: bleak or benign?

  2007cites this paper